A new study published in Science Advances details the success of an innovative eye stem cell transplant procedure. The procedure, called Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, was performed on four patients, with one patient, Phillip Durst, experiencing significant improvement in his vision. Durst had lost sight in his left eye due to a work accident a year prior and underwent the CALEC transplant in 2018, which made him eligible for an artificial corneal transplant. Durst’s success story highlights the potential of this procedure for restoring vision and improving the quality of life for individuals with severe eye damage.
